Tomohisa Okutsu

Title: Innovations by Tomohisa Okutsu in Therapeutic Agents

Introduction

Tomohisa Okutsu is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicine, specifically in the development of therapeutic agents aimed at treating inflammatory bowel disease. His inventive efforts have led to the filing of two patents that showcase innovative approaches to health care.

Latest Patents

One of Okutsu's latest patents focuses on a therapeutic agent for inflammatory bowel disease, which includes an inhibitor for TNF-α production. This innovative agent is formulated to treat or prevent inflammatory bowel disease and comprises various amino acids such as lysine, histidine, and tryptophan, administered at doses ranging from 0.1 to 4000 mg/kg per day. His second patent involves an isolated polypeptide that has a specific amino acid sequence significant in diagnosing human hepatitis. This polypeptide's expression is found to be notably lower in the livers of hepatitis patients compared to healthy individuals, offering a promising avenue for diagnostics.

Career Highlights

Okutsu is associated with Ajinomoto Co., Ltd., a leading company focused on food and biotechnology innovations. His work here emphasizes the importance of amino acids in health and highlights how they can be utilized in therapeutic applications to improve patients' quality of life.

Collaborations

During his career, Okutsu has collaborated with talented coworkers like Hideki Matsumoto and Tomoko Takeda. These partnerships have been instrumental in advancing his research and exploring new ideas in the realm of therapeutic inventions.

Conclusion

Tomohisa Okutsu's innovative patents reflect a deep commitment to enhancing medical treatments. His contributions underscore the importance of amino acids in therapeutic applications, paving the way for future research and developments in healthcare.